Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis

Optimal Use of Available Claims to Identify a Medicare Population Free of Coronary Heart Disease

(2015) Shia T. Kent et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources

(2015) Jeffrey R. Curtis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

(2014) Lotta Ljung et al.   ARTHRITIS RESEARCH & THERAPY

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

(2013) Bruce W Kirkham et al.   ANNALS OF THE RHEUMATIC DISEASES

HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

(2012) Hennie G Raterman et al.   ANNALS OF THE RHEUMATIC DISEASES

Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program

(2012) Sarah L. Cutrona et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Integrated safety in tocilizumab clinical trials

(2011) Michael H Schiff et al.   ARTHRITIS RESEARCH & THERAPY

Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis

(2010) J. D. Greenberg et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

(2009) G. Jones et al.   ANNALS OF THE RHEUMATIC DISEASES

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

(2008) Mark C. Genovese et al.   ARTHRITIS AND RHEUMATISM

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: A population-based cohort study

(2008) Hilal Maradit Kremers et al.   ARTHRITIS AND RHEUMATISM

Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies

(2008) J. Antonio Aviña-Zubieta et al.   ARTHRITIS AND RHEUMATISM

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

(2008) Antonio Naranjo et al.   ARTHRITIS RESEARCH & THERAPY